Abstract
Cytogenetic, molecular, and clinical genetic studies have contributed to our understanding of the etiology, pathogenesis, and natural history of DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS). Submicroscopic deletions of chromosome 22q11.2 are the leading cause of both of these disorders. The 22q11.2 deletion syndrome is recognized as one of the most common microdeletion syndromes. The clinical features are highly variable and include a variety of congenital anomalies, medical problems, and cognitive and neuropsychological difficulties.
Infrequently, other chromosomal rearrangements are found in patients with DGS/VCFS, and, rarely, point mutations in the gene TBX1, a transcription factor, that maps to the deleted region. The most sensitive and widely used diagnostic test for detecting the 22q11.2 deletion is fluorescence in situ hybridization using probes from the commonly deleted region. Alternatively, polymerase chain reaction can be performed to confirm failure to inherit a parental allele in the region or to determine copy number. Prenatal diagnosis is also available, particularly when a conotruncal cardiac defect is identified during a pregnancy or when a parent carries a deletion. Genetic counseling is recommended before testing to review the natural history of the disorder, testing options, and test sensitivity and limitations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
DiGeorge, A. M. (1965) Discussion on a new concept of the cellular basis of immunology. J. Pediatr. 67, 907.
Conley, M. E., Beckwith, J. B., Mancer, J. F. K., and Tenckhoff, L. (1979) The spectrum of the DiGeorge syndrome. J. Pediatr. 94, 883–890.
Lammer, E. J. and Opitz, J. M. (1986) The DiGeorge anomaly as a developmental field defect. Am. J. Med. Genet. 29, 113–127.
Scambler, P. J., Carey, A. H., Wyse, R. K. H., et al. (1991) Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics 20, 201–206.
Driscoll, D. A., Budarf, M. L., and Emanuel, B. S. (1992a) A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am. J. Hum. Genet. 50, 924–933.
Driscoll, D. A., Spinner, N. B., Budarf, M. L., et al. (1992b) Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am. J. Med. Genet. 44, 261–268.
Burn, J., Takao, A., Wilson, D., et al. (1993) Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22. J. Med. Genet. 30, 822–824.
Goldmuntz, E., Driscoll, D., Budarf, M. L., et al. (1993) Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects. J. Med. Genet. 30, 807–812.
Ryan, A. K., Goodship, J. A., Wilson, D. I., et al. (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J. Med. Genet. 34(10), 798–804.
McDonald-McGinn, D. M., Kirschner, R., Goldmuntz, E., et al. (1999) The Philadelphia Story: The 22q11.2 Deletion: Report on 250 Patients. Genetic. Counseling 10(1), 11–24.
Swillen, A., Vogels, A., Devriendt, K., Fryns, J. P. (2000) Chromosome 22q11 deletion syndrome: Update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am. J. Med. Genet. 97, 128–135.
Moss, E., Batshaw, M. L., Solot, C. B., et al. (1999) Psychoeducational profile of the 22q11.2 microdeletion: a comples pattern. J. Pediatr. 134, 193–198.
Woodin, M., Wang, P. P., Aleman, D., McDonald-McGinn, D., Zackai, E., Moss, E. (2001) Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet. Med. 3, 34–44.
Matsuoka, R., Takao, A., Kimura, M., et al. (1994) Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2. Am. J. Med. Genet. 53, 285–289.
McDonald-McGinn, D. M., Driscoll, D. A., Bason, L., et al. (1995) Autosomal dominant “Optiz” GBBB syndrome due to a 22q11.2 deletion. Am. J. Med. Genet. 59, 103–113.
Giannotti, A., Digilio, M. C., Marino, B., Mingarelli, R., and Dallapiccola, B. (1994) Cayler cardiofacial syndrome and del 22q11: Part of the CATCH22 phenotype. Am. J. Med. Genet. 53, 303–304.
Driscoll, D. A., Salvin, J., Sellinger, B., et al. (1993): Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J. Med. Genet. 30:813–817.
Lindsay, E. A., Greenberg, F., Shaffer, L. G,. Shapira, S. K., Scambler, P. J., and Baldini, A. (1995) Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region. Am. J. Med. Genet. 56, 191–197.
Devriendt, K., Fryns, J.-P., Van Thienen, M.-N., and Keymolen, K. (1998) The annual incidence of DiGeorge/velocardiofacial syndrome. J. Med. Genet. 35, 789–790.
Botto, L. D., May, K., Fernhoff, P. M., et al. (2003) A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112, 101–107.
Kelley, R. I., Zackai, E. H., Emanuel, B. S., Kistenmacher, M., Greenberg, F., and Punnett, H. H. (1982) The association of the DiGeorge anomalad with partial monosomy of chromosome 22. J. Pediatr. 101:197–200.
Greenberg, F. (1993) DiGeorge syndrome: an historical review of clinical and cytogenetic features. J. Med. Genet. 30, 803–806.
Goldmuntz, E., Clark, B. J., Mitchell, L. E., et al. (1998) Frequency of 22q11 deletions in patients with conotruncal defects. J. Am. Coll. Cardiol. 32, 492–298.
Fokstuen, S., Arbenz, U., Artan, S., et al. (1998) 22q11.2 deletions in a series of patients with non-selective congenital heart defects: incidence, type of defects and parental origin. Clin. Genet. 53, 64–69.
Voigt, R., Maier-Weidmann, M., Lange, P. E., and Haaf, T. (2002) Chromosome 10p13-14 and 22q11 deletion screening in 100 patients with isolated and syndromic conotruncal heart defects. J. Med. Genet. 39, e16.
Lewin, M. B., Lindsay, E. A., Jurecic, V., Goytia, V., Towbin, J. A., and Baldini, A. (1997) A genetic etiology for interruption of the aortic arch type B. Am. J. Cardiol. 80, 493–497.
Rauch, A., Hofbeck, M., Leipold, G., et al. (1998) Incidence and significance of 22q11.2 hemizygosity in patients with interrupted aortic arch. Am. J. Med. Genet. 78, 322–331.
Momma, K., Ando, M., Matsuoka, R. (1997) Truncus arteriosus communis associated with chromosome 22q11 deletion. J. Am. Coll. Cardiol. 30, 1067–1071.
McElhinney, D. B., Driscoll, D. A., Emanuel, B. S., and Goldmuntz, E. (2003) Chromosome 22q11 deletion in patients with truncus arteriosus. Pediatr. Cardiol. 24, 569–573.
McElhinney, D. B., Driscoll, D. A., Levin, E., Jawad, A. F., Emanuel, B. S., and Goldmuntz, E. (2003) Chromosome 22q11 deletion in patients with ventricular septal defect: frequency and associated cardiovascular anomalies. Pediatrics 112(6 Pt 1), e472–e476.
Lu, J.-H., Chung, M.-Y., Hwang, B., and Chien, H.-P. (1999) Prevalence and parental origin in Tetralogy of Fallot associated with chromosome 22q11 microdeletion. Pediatrics 104, 87–90.
Derbent, M., Yilmaz, Z., Baltaci, V., Saygih, A., Varan, B., and Tokel, K. (2003) Chromosome 22q11.2 deletion and phenotypic features in 30 patients with conotruncal heart defects. Am. J. Med. Genet. 116A, 129–135.
Digilio, M.C., Marino, B., Giannotti, A., Mingarelli, R., and Dallapiccola, B. (1999) Guidelines for 22q11 deletion screening of patients with conotruncal defects. J. Am. Col. Cardiol. 33, 1746–1747.
Goldmuntz, E., Clark, B. J., Mitchell, L. E., et al. (1999) Guidelines for 22q11.2 deletion screening of patients with conotruncal defects. J. Am. Col. Cardiol. Letter to the Editor. Reply. 33, 1747–1748.
Gerdes, M., Solot, S., Wang, P. P., McDonald-McGinn, D. M., and Zackai, E. Z. (2001) Taking advantage of early diagnosis: preschool children with the 22q11.2 deletion. Genet. Med. 3, 40–44.
Driscoll, D. A. (2001) Prenatal diagnosis of the 22q11.2 deletion syndrome. Genet. Med. 3, 14–18.
Manji, S., Roberson, J. R., Wiktor, A., et al. (2001) Prenatal diagnosis of 22q11.2 deletion when ultrasound examination reveals a heart defects. Genet. Med. 3, 65–66.
Iwarsson, E., Ahrlund-Richter, L., Inzunza, J., et al. (1998) Preimplantation genetic diagnosis of DiGeorge syndrome. Molec. Hum. Reprod. 4, 871–875.
Hatchwell, E., Long, F., Wilde, J., Crolla, J., and Temple, K. (1998) Molecular confirmation of germ line mosaicism for a submicroscopic deletion of chromosome 22q11. Am. J. Med. Genet. 78, 103–106.
Sandrin-Gardia, P., Macedo, C., Martelli, L. R., et al. (2002) Short report: recurrent 22q11.2 deletion in a sibship suggestive of parental germline mosaicism in velocardiofacial syndrome. Clin. Genet. 61, 380–383.
Desmaze, C., Scambler, P., Prieur, M., et al. (1993) Routine diagnosis of DiGeorge syndrome by fluorescent in situ hybridization. Hum. Genet. 90, 663–665.
Wilson, D. I., Cross, I. E., Goodship, J. A., et al. (1992) A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am. J. Hum. Genet. 51, 957–963.
Berend, S. A., Spikes, A. S., Kashork, C. D., et al. (2000) Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/ DiGeorge syndrome I and DiGeorge syndrome II loci. Am. J. Med. Genet. 91, 313–317.
Shaikh, T. S., Kurahashi, H., Saitta, S. C., et al. (2000) Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum. Molec. Genet. 9, 489–501.
Saitta, S. C., Harris, S. E., Gaeth, A. P., et al. (2004) Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion. Hum. Mol. Genet. 13, 417–428.
Rauch, A., Pfeiffer, R. A., Leipold, G., Singer, H., Tigges, M., and Hofbeck, M. (1999) A novel 22q11.2 microdeletion in DiGeorge syndrome. Am. J. Hum. Genet. 64, 659–666.
Saitta, S. C., McGrath, J. M., Mensch, H., Shaikh, T. H., Zackai, E. H., and Emanuel, B. S. (1999) A 22q11.2 deletion that excludes UFD1L and CDC45L in a patient with conotruncal and craniofacial defects. Am. J. Hum. Genet. 65, 562–566.
Merscher, S., Funke, B., Epstein, J.A., et al. (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104, 619–629.
Lindsay, E. A., Vitelli, F., Su, H., et al. (2002) tbx 1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410, 97–101.
Jerome, L. A. and Papaioannou, V. E. (2001) DiGeorge syndrome phenotype in mice mutant for the T-box gene, TBX1. Nat. Genet. 27, 286–291.
Gong, W., Gottlieb, S., Collins, J., et al. (2001) Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J. Med. Genet. 38, E45.
Conti, E., Grifone, N., Sarkozy, A., et al. (2003) DiGeorge subtypes of nonsyndromic conotruncal defects: evidence against a major role of TBX1 gene. Eur. J. Hum. Genet. 11, 349–351.
Yagi, H., Furutani, Y., Hamada, H., et al. (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362, 1366–1373.
Driscoll, D. A., Emanuel, B. S., Mitchell, L. E., and Budarf, M. L. (1997) PCR assay for screening patients at risk for 22q11.2 deletion. Genet. Test. 1, 109–113.
Bonnet, D., Cormier-Daire, V., Kachaner, J., et al. (1997) Microsatellite DNA markers detects 95% of chromosome 22q11 deletions. Am. J. Med. Genet. 68, 182–184.
Saitta, S. C., Harris, S. E., McDonald-McGinn, D. M., et al. (2004) Independent de novo 22q11.2 deletions in first cousins with DiGeorge/velocardiofacial syndrome. Am. J. Med. Genet. 124A, 313–317.
Kariyazono, J., Ohno, T., Ihara, K., et al. (2001) Rapid detection of the 22q11.2 deletion with quantitative real-time PCR. Molec. Cell. Probes 25, 71–73.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Driscoll, D.A. (2006). Molecular and Genetic Aspects of DiGeorge/Velocardiofacial Syndrome. In: Kearns-Jonker, M. (eds) Congenital Heart Disease. Methods in Molecular Medicine, vol 126. Humana Press. https://doi.org/10.1385/1-59745-088-X:43
Download citation
DOI: https://doi.org/10.1385/1-59745-088-X:43
Publisher Name: Humana Press
Print ISBN: 978-1-58829-375-6
Online ISBN: 978-1-59745-088-1
eBook Packages: Springer Protocols